1. Executive Summary 2. Market Size & Analysis: United States Pediatric Vaccines (2010 – 2025) 3. United States Pediatric Vaccines Market Share and Y–o–Y Growth (%) 4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market 4.1 Market Drivers 4.2 Market Inhibitors 5. United States Pediatric Vaccines Market – By Disease Indication (2010 – 2025) 5.1 Diphtheria, Tetanus & Pertussis (DTap) 5.1.1 Doses Administered (Volume) 5.1.2 Number of Children Being Vaccinated (Volume) 5.1.3 Market Size and Forecast(Value) 5.2 Hepatitis A 5.2.1 Doses Administered(Volume) 5.2.2 Number of Children Being Vaccinated(Volume) 5.2.3 Market Size and Forecast(Value) 5.3 Varicella / Chicken Pox 5.3.1 Doses Administered(Volume) 5.3.2 Number of Children Being Vaccinated(Volume) 5.3.3 Market Size and Forecast(Value) 5.4 Pneumococcal 5.4.1 Doses Administered(Volume) 5.4.2 Number of Children Being Vaccinated(Volume) 5.4.3 Market Size and Forecast(Value) 5.5 Haemophilus Influenzae Type B (HIB) 5.5.1 Doses Administered(Volume) 5.5.2 Number of Children Being Vaccinated(Volume) 5.5.3 Market Size and Forecast(Value) 5.6 Polio 5.6.1 Doses Administered(Volume) 5.6.2 Number of Children Being Vaccinated(Volume) 5.6.3 Market Size and Forecast(Value) 5.7 Rotavirus 5.7.1 Doses Administered(Volume) 5.7.2 Number of Children Being Vaccinated(Volume) 5.7.3 Market Size and Forecast(Value) 5.8 Hepatitis B 5.8.1 Doses Administered(Volume) 5.8.2 Number of Children Being Vaccinated(Volume) 5.8.3 Market Size and Forecast(Value) 5.9 Influenza Pediatric 5.9.1 Doses Administered(Volume) 5.9.2 Number of Children Being Vaccinated(Volume) 5.9.3 Market Size and Forecast(Value) 5.10 Measles, Mumps & Rubella (MMR) 5.10.1 Doses Administered(Volume) 5.10.2 Number of Children Being Vaccinated(Volume) 5.10.3 Market Size and Forecast(Value) 6. Key Companies Analysis 6.1 Sanofi Pasteur 6.1.1 Business Overview 6.1.2 Pediatric Vaccines Portfolio 6.1.3 Pedaitric Vaccines – Latest Development & Trends 6.2 GlaxoSmithKline (GSK) 6.2.1 Business Overview 6.2.2 Pediatric Vaccines Portfolio 6.2.3 Pediatric Vaccines – Latest Development & Trends 6.3 Merck & Co 6.3.1 Business Overview 6.3.2 Pediatric Vaccines Portfolio 6.3.3 Pediatric Vaccines – Latest Development & Trends 6.4 Pfizer Inc 6.4.1 Business Overview 6.4.2 Pediatric Vaccines Portfolios 6.4.3 Pediatric Vaccines – Latest Development & Trends 6.5 Grifols 6.5.1 Business Overview 6.5.2 Pediatric Vaccines Portfolio 6.5.3 Pediatric Vaccines – Latest Development & Trends

Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2010 – 2017 Table 3–2: United States Pediatric Vaccines Market Share Forecast (Percent), 2018 – 2025 Figure 2–1: United States Pediatric Vaccines Market (Million US$), 2010 – 2017 Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2018 – 2025 Figure 5–1: DTap Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–2: DTap Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–3: Number of Children Being Vaccinated with DTap Vaccines (in Million), 2010 – 2017 Figure 5–4: Number of Children Being Vaccinated with DTap Vaccines Forecast (in Million), 2018 –2025 Figure 5–5: DTap Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–6: DTap Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–7: Hepatitis A Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–8: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–9: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million),2010 – 2017 Figure 5–10: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million),2018 – 2025 Figure 5–11: Hepatitis A Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–12: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–13: Varicella Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–14: Varicella Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–15: Number of Children Being Vaccinated with Varicella Vaccines (in Million),2010 – 2017 Figure 5–16: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million),2018 – 2025 Figure 5–17: Varicella Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–18: Varicella Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–19: Pneumococcal Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–20: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–21: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million),2010 – 2017 Figure 5–22: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million),2018 – 2025 Figure 5–23: Pneumococcal Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–24: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–25: HIB Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–26: HIB Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–27: Number of Children Being Vaccinated with HIB Vaccines (in Million),2010 – 2017 Figure 5–28: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million),2018 – 2025 Figure 5–29: HIB Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–30: HIB Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–31: Polio Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–32: Polio Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–33: Number of Children Being Vaccinated with Polio Vaccines (in Million),2010 – 2017 Figure 5–34: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million),2018 –2025 Figure 5–35: Polio Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–36: Polio Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–37: Rotavirus Vaccines Doses Administered (in Million), 2010–2017 Figure 5–38: Rotavirus Vaccines Doses Administered Forecast (in Million), 2018–2025 Figure 5–39: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million),2010 – 2017 Figure 5–40: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million),2018 –2025 Figure 5–41: Rotavirus Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–42: Rotavirus Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–43: Hepatitis B Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–44: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–45: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million),2010 – 2017 Figure 5–46: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million),2018 – 2025 Figure 5–47: Hepatitis B Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–48: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–49: Influenza Pediatric Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–50: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–51: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million),2010 – 2017 Figure 5–52: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million),2018 – 2025 Figure 5–53: Influenza Pediatric Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–54: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2018 – 2025 Figure 5–55: MMR Vaccines Doses Administered (in Million), 2010 – 2017 Figure 5–56: MMR Vaccines Doses Administered Forecast (in Million), 2018 – 2025 Figure 5–57: Number of Children Being Vaccinated with MMR Vaccines (in Million),2010 – 2017 Figure 5–58: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million),2018 – 2025 Figure 5–59: MMR Vaccines Market Value (in Million US$), 2010 – 2017 Figure 5–60: MMR Vaccines Market Value Forecast (in Million US$), 2018 – 2025

Sanofi Pasteur, GlaxoSmithKline (GSK), Merck & Co, Pfizer Inc, Grifols